Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Phase II Trial of JKB-121 for the Treatment of Nonalcoholic Steatohepatitis (NASH)

NCT02442687 is registered in ClinicalTrials.gov with Manal Abdelmalek as lead sponsor.

NCT NCT02442687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02442687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Phase II Trial of JKB-121 for the Treatment of Nonalcoholic Steatohepatitis (NASH)
Lead sponsor
Manal Abdelmalek
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2015
Completion date
September 24, 2017
Enrollment
65 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic steatohepatitis